Persistence of Anti-S1 IgG against SARS-CoV-2 Eight Months after the Booster Dose of Vaccine in Naive and Previously Infected Healthcare Workers

Persistence of Anti-S1 IgG against SARS-CoV-2 Eight Months after the Booster Dose of Vaccine in Naive and Previously Infected Healthcare Workers

Our aim was to evaluate the immune response of healthcare workers included in the RIPOVAC study, after receiving a booster dose (third dose), in terms of intensity and persistence of induced antibodies. In the second phase of the RIPOVAC study, between December 2021 and January 2022, eight months af...

Full description

Bibliographic Details
Main Authors: Sonia Algarate, Laura Serrano, Jessica Bueno, Beatriz Herrero-Cortina, Elena Alvarado, María T. González-Barriga, María Ducons, Jesica Montero-Marco, Sara Arnal, Beatriz Acha, María Riesgo, Ana Taboada, Pilar Sanz-Burillo, Cristina Yuste, Rafael Benito, on behalf of the RIPOVAC Study Group
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:International Journal of Molecular Sciences
Subjects:
SARS-CoV-2
booster vaccine
post-vaccine IgG antibody persistence
Online Access:https://www.mdpi.com/1422-0067/24/13/10713

Similar Items

Similar Items